ARTICLE | Clinical News
Pfizer preclinical data
July 26, 2010 7:00 AM UTC
In mouse models of hemophilia, Pfizer's activated recombinant Factor Xa variant corrected bleeding. Data were presented at the World Federation of Hemophilia Congress in Buenos Aires. ...